Purchase Order 75F40124P00145
Award Date
4/29/24
Potential Completion Date
9/30/24
Potential Value
$47K
Federal Agency
Food and Drug Administration
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Menlo Park, CA 94025, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed price purchase order awarded by the Food and Drug Administration (FDA) to Pacific Biosciences of California, Inc. for $24,357.60 to provide PacBio reagents. The contract has a completion date of September 30, 2024 and does not have a set-aside designation. Pacific Biosciences is the original equipment manufacturer of the Sequel and Sequel II DNA/RNA sequencing platforms, which are used by federal agencies like the FDA, CDC, USDA, and NIH to support genomic research across...
This federal contract award to Pacific Biosciences of California, Inc., a small business manufacturer, is for the provision of a Sequel IIE long-read DNA/RNA sequencer system and associated consumables. The $726,318.04 firm-fixed-price purchase order was awarded by the Food and Drug Administration (FDA) to support the National Antimicrobial Resistance Monitoring System. The award is directly related to a previous FDA solicitation that sought a long-read sequencing instrument with a minimum...
This is a $504,000.00 firm fixed price purchase order awarded by the Food and Drug Administration (FDA) to Pacific Biosciences of California, Inc. for a standard PacBio service contract with a base period plus four option years. The contract is for the provision of PART NUMBER 100-236-400 and is not set aside. Pacific Biosciences is the original equipment manufacturer of the Sequel and Sequel II DNA/RNA sequencing platforms, which are utilized by various federal agencies to support genomic...
This contract award to Pacific Biosciences of California, Inc., a small business manufacturer, is for the provision of high-throughput, long-read DNA sequencing systems and associated consumables to the U.S. Food and Drug Administration (FDA). The $83,644 firm fixed-price purchase order has an ultimate completion date of October 14, 2015. Pacific Biosciences is the original equipment manufacturer for their proprietary single molecule, real-time (SMRT) sequencing technology, which is utilized...
This firm-fixed-price purchase order was awarded to Pacific Biosciences of California, Inc. (PacBio), a leading manufacturer of high-throughput DNA sequencing systems and related consumables, by the U.S. Food and Drug Administration (FDA). The $48,715.20 contract is for the delivery of PacBio's Revio Reagent Kit, part number 102-817-900, with a period of performance through September 9, 2024. PacBio holds two significant IDIQ contract vehicles with federal agencies - a $13.5 million IDIQ with...
This is a firm-fixed price purchase order contract awarded by the Food and Drug Administration (FDA) to Pacific Biosciences of California, Inc., a small business manufacturer of genomic sequencing instruments and consumables. The contract is for the delivery of reagents and consumables for the FDA's PacBio Revio sequencing instrument system. The award has a ceiling value of $40,473.60 and a period of performance through September 30, 2025. This award was issued under a total small business...
The U.S. Food and Drug Administration (FDA) has awarded a $39,657.00 firm fixed-price delivery order to Pacific Biosciences of California, Inc. (PacBio) under the company's existing $1 million Indefinite Delivery, Indefinite Quantity (IDIQ) contract with the agency. This delivery order is for the purchase of specific supplies and reagents to support the agency's use of PacBio's Sequel IIe long-read DNA/RNA sequencing platform. The award, made without a set-aside designation, is the latest task...
This contract award is for the purchase of reagents and supplies from Pacific Biosciences of California, Inc. by the U.S. Department of Health and Human Services' Food and Drug Administration. The items include PacBio's proprietary single molecule real-time (SMRT) sequencing consumables such as template prep kits, binding kits, and SMRT cells to support the agency's genomic research initiatives. The $46,548 firm-fixed price delivery order does not utilize a set-aside program. Pacific Biosciences...
This is a $505,454 firm-fixed price purchase order contract awarded by the Food and Drug Administration (FDA) to Pacific Biosciences of California, Inc., a small business manufacturer of advanced DNA sequencing systems and reagents. The contract is for the delivery of a "REAL TIME DNA SEQUENCER" and is set aside for small business. Pacific Biosciences specializes in their proprietary single molecule, real-time (SMRT) sequencing technology, which is utilized by various federal...
This federal contract award is for the procurement of PacBio Sequel II and IIe system reagents and consumables by the Food and Drug Administration (FDA). The $15,713.10 firm-fixed price contract was awarded on July 23, 2024 to Pacific Biosciences of California, Inc., a leading manufacturer of high-throughput, long-read DNA sequencing platforms and associated products. The contract does not have a set-aside designation. Pacific Biosciences holds two relevant Indefinite Delivery Indefinite...